News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Özcan Met: The first patient with melanoma received TILs edited with non-viral CRISPR technology
Özcan Met/LinkedIn
Feb 3, 2025, 13:46

Özcan Met: The first patient with melanoma received TILs edited with non-viral CRISPR technology

Özcan Met, Associate Professor and Head of Cell Therapy Unit at National Center for Cancer Immune Therapy, posted on LinkedIn:

“This week, the first patient with melanoma received TILs edited with non-viral CRISPR technology – a truly exciting step forward in cell therapy! As someone deeply involved in academic ATMP development, moments like this a powerful reminder of why we do what we do!

Academic trials play a crucial role in bringing innovative therapies from the lab to the clinic, often paving the way for future breakthroughs. They allow us to explore cutting-edge technologies, refine our approaches, and most importantly, offer new hope to patients.

Well done team!”

cancer CRISPR technology Melanoma OncoDaily Oncology Özcan Met
Special Coverage
Blog
Feb 3, 2025, 13:54
Register to attend the EHA-EBMT 7th European CAR T-cell Meeting
Blog
Feb 3, 2025, 13:51
4 questions for mathematical oncologist Heiko Enderling - MD Anderson Cancer Center
Blog
Feb 3, 2025, 13:46
Özcan Met: The first patient with melanoma received TILs edited with non-viral CRISPR technology
Blog
Feb 3, 2025, 13:44
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer
Insight
Feb 3, 2025, 13:12
Supriya Peshin: Bosutinib-induced pleural effusion - class effect and cross-intolerance to all TKIs
Opinion
Feb 3, 2025, 13:10
Gustavo Viani: Does acute toxicity predict late toxicity in prostate radiotherapy?
Blog
Feb 3, 2025, 13:06
Stephen V Liu: Grateful for the chance to learn from the top lung cancer experts at ITCD2025
Blog
Feb 3, 2025, 12:59
Hot Topic: Data Table 2 - Association of Cancer Center Administrators
Societies
Feb 3, 2025, 12:57
Keeping up with WLC25 by Estela Rodriguez
Science
Feb 3, 2025, 12:47
Myeloma Paper of the Day, February 3rd, suggested by Robert Orlowski
Blog
Feb 3, 2025, 12:46
Patrick Hwu: Identifying neoantigens from metastatic tumors
Blog
Feb 3, 2025, 12:02
A new month brings new opportunities to make an impact - Medicaid Cancer Foundation